KR20070085470A - 핫플러쉬 치료용 ｓ-미르타자핀 - Google Patents

핫플러쉬 치료용 ｓ-미르타자핀 Download PDF

Info

Publication number
KR20070085470A
KR20070085470A KR1020077011981A KR20077011981A KR20070085470A KR 20070085470 A KR20070085470 A KR 20070085470A KR 1020077011981 A KR1020077011981 A KR 1020077011981A KR 20077011981 A KR20077011981 A KR 20077011981A KR 20070085470 A KR20070085470 A KR 20070085470A
Authority
KR
South Korea
Prior art keywords
mirtazapine
treatment
rats
day
hot flush
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020077011981A
Other languages
English (en)
Korean (ko)
Inventor
비.더블유.엠.엠. 베르나르더스 피이터스
안톤 에그버르트 피터 아당
Original Assignee
엔.브이.오가논
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34929859&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20070085470(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 엔.브이.오가논 filed Critical 엔.브이.오가논
Publication of KR20070085470A publication Critical patent/KR20070085470A/ko
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
KR1020077011981A 2004-11-15 2005-11-14 핫플러쉬 치료용 ｓ-미르타자핀 Ceased KR20070085470A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04105778 2004-11-15
EP04105778.7 2004-11-15

Publications (1)

Publication Number Publication Date
KR20070085470A true KR20070085470A (ko) 2007-08-27

Family

ID=34929859

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077011981A Ceased KR20070085470A (ko) 2004-11-15 2005-11-14 핫플러쉬 치료용 ｓ-미르타자핀

Country Status (30)

Country Link
US (4) US20070265245A1 (https=)
EP (1) EP1814555B1 (https=)
JP (1) JP2008519810A (https=)
KR (1) KR20070085470A (https=)
CN (2) CN102772414A (https=)
AR (1) AR053780A1 (https=)
AT (1) ATE439843T1 (https=)
AU (1) AU2005303778B2 (https=)
BR (1) BRPI0517818A2 (https=)
CA (1) CA2587283C (https=)
CY (1) CY1110538T1 (https=)
DE (1) DE602005016141D1 (https=)
DK (1) DK1814555T3 (https=)
ES (1) ES2329815T3 (https=)
HR (1) HRP20090513T1 (https=)
IL (1) IL182767A (https=)
MX (1) MX2007005827A (https=)
MY (1) MY144089A (https=)
NO (1) NO20072285L (https=)
NZ (1) NZ554858A (https=)
PE (1) PE20061051A1 (https=)
PL (1) PL1814555T3 (https=)
PT (1) PT1814555E (https=)
RS (1) RS51138B (https=)
RU (1) RU2396957C2 (https=)
SI (1) SI1814555T1 (https=)
TW (1) TW200631584A (https=)
UA (1) UA88655C2 (https=)
WO (1) WO2006051111A1 (https=)
ZA (1) ZA200703884B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1898919A2 (en) * 2005-06-27 2008-03-19 N.V. Organon A method of treatment of hormone depletion induced vasomotor symptoms
US20070129611A1 (en) * 2005-12-06 2007-06-07 University Of North Texas Health Science Center At Fort Worth System, Method and Apparatus for Assessing Menopausal or Post-Hysterectomy Symptoms
EP1993556A1 (en) * 2006-03-06 2008-11-26 N.V. Organon An improved method of weaning from hormonal treatment of hormone depletion induced vasomotor symptoms
WO2008062021A1 (en) * 2006-11-22 2008-05-29 N.V. Organon Vaginal delivery system for mirtazapine
US7645750B2 (en) * 2006-12-13 2010-01-12 Yung Shin Pharmaceutical Ind. Co., Ltd. Method of treating symptoms of hormonal variations
JP2009018992A (ja) 2007-07-10 2009-01-29 Sumitomo Chemical Co Ltd 光学活性ミルタザピンの製造方法
US8420624B2 (en) 2007-12-04 2013-04-16 Yung Shin Pharm. Ind. Co., Ltd. Methods for treating or preventing symptoms of hormonal variations
WO2016138357A1 (en) 2015-02-27 2016-09-01 Kindred Biosciences, Inc. Stimulation of appetite, management of weight loss, and treatment of anorexia in dogs and cats
CA3064846A1 (en) * 2017-05-25 2018-11-29 Glytech, Llc Combined therapy for nmdar antagonist-responsive neuropsychiatric disorders
US12564288B2 (en) 2020-02-19 2026-03-03 Ivan Ulinich Universal device for heat treating food products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
JPH1187727A (ja) * 1997-09-12 1999-03-30 Mitsubishi Electric Corp 半導体装置
DE69913116T2 (de) * 1998-04-02 2004-06-03 Akzo Nobel N.V. Orale flüssige lösung enthaltend das antidepressivum mirtazapine
RU2195951C1 (ru) * 2001-08-20 2003-01-10 Общество с ограниченной ответственностью "Лаборатория "Ирис" Средство для лечения климактерических расстройств

Also Published As

Publication number Publication date
DE602005016141D1 (de) 2009-10-01
TW200631584A (en) 2006-09-16
US20120302552A1 (en) 2012-11-29
CN102772414A (zh) 2012-11-14
WO2006051111A1 (en) 2006-05-18
ZA200703884B (en) 2009-07-29
JP2008519810A (ja) 2008-06-12
NZ554858A (en) 2009-10-30
ES2329815T3 (es) 2009-12-01
CN101056641A (zh) 2007-10-17
US20100267694A1 (en) 2010-10-21
PT1814555E (pt) 2009-09-30
CA2587283C (en) 2013-01-15
ATE439843T1 (de) 2009-09-15
AU2005303778B2 (en) 2011-02-17
US20070265245A1 (en) 2007-11-15
UA88655C2 (ru) 2009-11-10
HRP20090513T1 (hr) 2009-10-31
DK1814555T3 (da) 2009-12-07
IL182767A0 (en) 2007-09-20
MX2007005827A (es) 2007-07-20
IL182767A (en) 2011-07-31
HK1104235A1 (en) 2008-01-11
CY1110538T1 (el) 2015-04-29
SI1814555T1 (sl) 2009-12-31
RS51138B (sr) 2010-10-31
NO20072285L (no) 2007-06-13
EP1814555A1 (en) 2007-08-08
PL1814555T3 (pl) 2010-01-29
CA2587283A1 (en) 2006-05-18
RU2396957C2 (ru) 2010-08-20
BRPI0517818A2 (pt) 2010-03-16
MY144089A (en) 2011-08-15
AU2005303778A1 (en) 2006-05-18
US20130225559A1 (en) 2013-08-29
EP1814555B1 (en) 2009-08-19
AR053780A1 (es) 2007-05-23
RU2007122391A (ru) 2008-12-20
PE20061051A1 (es) 2006-10-26

Similar Documents

Publication Publication Date Title
RU2177786C2 (ru) Составы для модулирования сексуальной реакции человека
US20120302552A1 (en) S-mirtazapine for the treatment of hot flush
TWI330083B (en) Methods for treating or preventing symptoms of hormonal variations
JP2001515032A (ja) 前立腺がんを治療するためのチロシンキナーゼ阻害剤と化学的去勢術の組み合わせ法
JP2009280621A (ja) ヒトの性応答を調節するための組み合わせ治療
IL148159A (en) Methods in Depoxytin Ann is a common pharmacological word in the manufacture of a drug for the treatment or control of sexual dysfunction
WO2015127556A1 (en) Methods and uses for inducing or facilitating defecation in a patient in need thereof
US11224603B2 (en) Antihistamines in combination with a range of substances for improved health
CN120775005A (zh) 一种多肽组合物及其在用于治疗男性勃起功能障碍中的用途
HK1104235B (en) S-mirtazapine for the treatment of hot flush
JP2000514441A (ja) 月経前症候群の１又は複数の症状を抑制するための医薬組成物の製造のための３，４―ジフェニルクロマンの使用
CN118059105A (zh) 一种降血压的药物组合物
US20090170900A1 (en) Dosing regimen for weight loss
TW202317135A (zh) 選擇性雌激素受體共價拮抗劑與cdk4/6抑制劑聯合在製備治療乳腺癌藥物中的用途
WO2007016771A1 (en) Dosing regimen for weight loss
MXPA99010400A (en) Combination therapy for modulating the human sexual response

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20070528

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20101110

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20121012

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20130429

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20121012

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I